Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-30 Purchase |
2021-03-31 7:12 pm |
Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director |
15,625 | $16 | $250,000 | 3,489,168 (Indirect Direct) |
View |
| 2021-03-30 Purchase |
2021-03-31 7:11 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
359,375 | $16 | $5,750,000 | 13,359,456 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-03-31 7:10 pm |
Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
359,375 | $16 | $5,750,000 | 13,359,456 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-03-31 4:36 pm |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
625,000 | $16 | $10,000,000 | 5,587,207 (Direct) |
View |
| 2021-03-30 Purchase |
2021-03-30 3:42 pm |
Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Possible Member of 10% Group 10% Owner |
625,000 | $16 | $10,000,000 | 3,933,137 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-04 4:34 pm |
N/A 2031-04-30 |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-03-30 Conversion |
2021-03-31 7:12 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director |
6,947,086 | $0 | 3,489,168 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-03-31 7:11 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
25,732,796 | $0 | 13,359,456 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-03-31 7:10 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
25,732,796 | $0 | 13,359,456 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-03-31 4:36 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
9,924,414 | $0 | 5,587,207 (Direct) |
View |
| 2021-03-30 Conversion |
2021-03-30 5:12 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
681,812 | $0 | 681,812 (Direct) |
View |
| 2021-03-30 Conversion |
2021-03-30 3:42 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Possible Member of 10% Group 10% Owner |
3,308,137 | $0 | 3,933,137 (Indirect) |
View |
Ownership |
2021-03-25 9:40 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
0 | $0 | 13,319,680 (Indirect) |
View |
Ownership |
2021-03-25 9:40 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
0 | $0 | 2,991,469 (Direct) |
View |
Ownership |
2021-03-25 9:39 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director |
0 | $0 | 3,473,543 (Indirect) |
View |
Ownership |
2021-03-25 9:39 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 13,319,680 (Indirect) |
View |
Ownership |
2021-03-25 9:38 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
0 | $0 | 443,180 (Direct) |
View |
Ownership |
2021-03-25 9:38 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
0 | $0 | 2,105,104 (Indirect) |
View |
Ownership |
2021-03-25 9:36 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
0 | $0 | 135,561 (Direct) |
View |
Ownership |
2021-03-25 9:35 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
0 | $0 | 135,561 (Direct) |
View |
Ownership |
2021-03-25 9:35 pm |
N/A 2030-09-21 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
0 | $0 | 443,180 (Direct) |
View |
Ownership |
2021-03-25 9:34 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
0 | $0 | 443,180 (Direct) |
View |
Ownership |
2021-03-25 9:34 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Brege Laura Director |
0 | $0 | 88,636 (Direct) |
View |
Ownership |
2021-03-25 9:28 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
0 | $0 | 681,812 (Direct) |
View |
Ownership |
2021-03-25 8:34 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Novo Holdings A/S 10% Owner |
0 | $0 | 4,962,207 (Direct) |
View |
Ownership |
2021-03-25 6:27 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Flynn James E Deerfield Mgmt IV L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund IV L.P. Possible Member of 10% Group 10% Owner |
0 | $0 | 3,308,137 (Indirect) |
View |